692 / 1068
Chinese Study
Inclusion criteria: cT3-4 or N+
R
RT 50 Gy
(@2.0 Gy)
+
Capecitabine 1600 mg/m²
days 1-14 + 22-25
T
M
E
FOLFOX
6-8 cycles
Primary endpoint: 3y-OS (84 to 96%); 206 pts
RT 50 Gy
(@2.0 Gy)
+
Capecitabine 1600 mg/m²
days 1-14 + 22-25
Oxaliplatin 60 mg/m² d 1, 8 + 22, 29
T
M
E
FOLFOX
6-8 cycles